Novel Targets for Treatment of Pseudomonas aeruginosa Biofilms - Antibiofilm Agents: From Diagnosis to Treatment and Prevention - page 263

Nilsson E et al (2008) Good effect of IgY against Pseudomonas aeruginosa infections in cystic
fibrosis patients. Pediatr Pulmonol 43(9):892-899
Oncel S et al (2010) Evaluation of bacterial biofilms in chronic rhinosinusitis. J Otolaryngol Head
Neck Surg 39(1):52-55
Pamp SJ et al (2008) Tolerance to the antimicrobial peptide colistin in Pseudomonas aeruginosa
biofilms is linked to metabolically active cells, and depends on the pmr and mexAB-oprM
genes. Mol Microbiol 68(1):223-240
Parks QM et al (2009) Neutrophil enhancement of Pseudomonas aeruginosa biofilm development:
human F-actin and DNA as targets for therapy. J Med Microbiol 58(Pt 4):492-502
Parsons D et al (2005) Silver antimicrobial dressings in wound management: a comparison of
antibacterial, physical, and chemical characteristics. Wounds 17(8):222-232
Pollack M et al (1984) Immunization with Pseudomonas aeruginosa high-molecular-weight
polysaccharides prevents death from Pseudomonas burn infections in mice. Infect Immun 43
(2):759-760
Post JC (2001) Direct evidence of bacterial biofilms in otitis media. Laryngoscope 111(12):2083-
2094
Rasmussen TB et al (2005) Identity and effects of quorum-sensing inhibitors produced by
Penicillium species. Microbiology 151(Pt 5):1325-1340
Reyes MP, Lerner AM (1983) Current problems in the treatment of infective endocarditis due to
Pseudomonas aeruginosa . Rev Infect Dis 5(2):314-321
Robinson PJ (2002) Dornase alfa in early cystic fibrosis lung disease. Pediatr Pulmonol 34(3):237-
241
Sapico FL (1996) Microbiology and antimicrobial therapy of spinal infections. Orthop Clin North
Am 27(1):9-13
Schaedel C et al (2002) Predictors of deterioration of lung function in cystic fibrosis. Pediatr
Pulmonol 33(6):483-491
Shanks KK et al (2010) Interleukin-8 production by human airway epithelial cells in response to
Pseudomonas aeruginosa clinical isolates expressing type a or type b flagellins. Clin Vaccine
Immunol 17(8):1196-1202
Shapiro JA (1998) Thinking about bacterial populations as multicellular organisms. Annu Rev
Microbiol 52(1):81-104
Skindersø ME et al (2008) Effects of antibiotics on quorum sensing in Pseudomonas aeruginosa .
Antimicrob Agents Chemother 52(10):3648-3663
Smith RS, Iglewski BH (2003) P. aeruginosa quorum-sensing systems and virulence. Curr Opin
Microbiol 6(1):56-60
Smith KD et al (2003) Toll-like receptor 5 recognizes a conserved site on flagellin required for
protofilament formation and bacterial motility. Nat Immunol 4(12):1247-1253
Spellberg B et al (2008) The epidemic of antibiotic-resistant infections: a call to action for the
medical community from the Infectious Diseases Society of America. Clin Infect Dis 46
(2):155-164
Stewart PS, Costerton JW (2001) Antibiotic resistance of bacteria in biofilms. Lancet 358
(9276):135-138
Storm-Versloot MN et al (2010) Topical silver for preventing wound infection. Cochrane Data-
base Syst Rev(3):CD006478
Stover CK et al (2000) Complete genome sequence of Pseudomonas aeruginosa PAO1, an
opportunistic pathogen. Nature 406(6799):959-964
Sun D et al (2005) Inhibition of biofilm formation by monoclonal antibodies against Staphylo-
coccus epidermidis RP62A accumulation-associated protein. Clin Diagn Lab Immunol 12
(1):93-100
Tacconelli E et al (2009) Epidemiology, medical outcomes and costs of catheter-related blood-
stream infections in intensive care units of four European countries: literature- and registry-
based estimates. J Hosp Infect 72(2):97-103